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Background: Major depression (MD) is one of the most frequent diagnoses in Primary Care. It is a disabling illness
that increases the use of health resources. Aim: To describe the concordance between remission according to
clinical assessment and remission obtained from the computerized prescription databases of patients with MD in a
Spanish population.
Methods: Design: multicenter cross-sectional. The population under study was comprised of people from six
primary care facilities, who had a MD episode between January 2003 and March 2007. A specialist in psychiatry
assessed a random sample of patient histories and determined whether a certain patient was in remission
according to clinical criteria (ICPC-2). Regarding the databases, patients were considered in remission when they
did not need further prescriptions of AD for at least 6 months after completing treatment for a new episode.
Validity indicators (sensitivity [S], specificity [Sp]) and clinical utility (positive and negative probability ratio [PPR] and
[NPR]) were calculated. The concordance index was established using Cohen’s kappa coefficient. Significance level
was p < 0.05.
Results: 133 patient histories were reviewed. The kappa coefficient was 82.8% (confidence intervals [CI] were 95%:
73.1 - 92.6), PPR 9.8% and NPR 0.1%. Allocation discrepancies between both criteria were found in 11 patients. S
was 92.5% (CI was 95%: 88.0 - 96.9%) and Sp was 90.6% (CI was 95%: 85.6 - 95.6%), p < 0.001. Reliability analysis:
Cronbach’s alpha: 90.6% (CI was 95%: 85.6 - 95.6%).
Conclusions: Results show an acceptable level of concordance between remission obtained from the
computerized databases and clinical criteria. The major discrepancies were found in diagnostic accuracy.
Background
Major depression (MD) is one of the most frequent
diagnoses in Primary Care (PC) and in the general
population [1]. It is a disabling illness that alters
patients’ quality of life and causes an increase in the use
of health resources [2-6]. It is important to define the
therapeutic objectives for MD [7], and more experts are
claiming that reaching remission should be the main
objective since residual symptoms prolong psychosocial
dysfunction and can cause higher rates of recurrence
[8-10]. In this respect, antidepressants (AD) constitute
the pillar of pharmacological treatment in order to
achieve the sustained remission of symptoms [11,12].
On the other hand, some prospective naturalistic stu-
dies are carried out in order to explore health problems
using computerized databases; because key data in these
databases are prescriptions or pharmacy claims, and
because there is no specific clinical data recorded in
these databases it is usually not possible to obtain qual-
ity data to measure remission, thus necessitating
“approximate definitions”. No consensus currently exists
regarding a definition of an approximation for remis-
sion. However, definitions exist for depression episode:
usually, a new episode for depression is defined as
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depressant prescription in the previous 6 months [12].
From this, it can be derived that if a patient stops treat-
ment and has no new prescription during the following
6 months, he/she has completed a depression episode. If
he/she starts an antidepressant after that, it will be a
new episode. This can be used in a model for remission.
Nevertheless, this “approximate definition” can cause
several problems. On one hand, there may be other
motives for discontinuing the prescription other than
the patient being in remission (failure to observe treat-
ment, adverse side effects, etc.). On the other hand, per-
sistence of treatment with AD should not always be
interpreted as absence of remission, as it is indicated in
all patients for 6-9 months after achieving remission,
a n df o ral o n g e rp e r i o di ns e l e c t e dp a t i e n t sa tr i s ko f
relapse [13].
Thus, it is pertinent to prove the validity of this con-
struct, so as not to fall into classification bias [14], espe-
cially when there is no evidence at present in the
revised literature. This study is an attempt to comple-
ment a previously started line of investigation on remis-
sion in patients with MD (results pending publication).
The purpose of this study is to describe the validity
(reliability, concordance) and the clinical utility of the
remission measurement obtained from the direct review
of patients’ histories (reference criteria) and the one
taken from the database registry (by approximation) in
MD patients in a Spanish population.
Methods
Design and population under study
The design was cross-sectional and multi-centric. The
population under study was comprised of people from
six primary care facilities under the management of
Badalona Serveis Assistencials SA, which provide health
care for some 107,208 people, out of whom 15.9% are
o v e r6 4 .T h ed i a g n o s i so fM Dw a sm a d ea c c o r d i n gt o
International Classification of Primary Care (ICPC-2;
code P76) [15]. The following scales were used for
screening/diagnostics: Goldberg (co-existence of psy-
chiatric morbidity), Hamilton Depression (severity of
depression symptoms) and Yesavage Geriatric Depres-
sion [11]. Patients were selected according to the follow-
ing criteria: a) over 17 years old, b) who have initiated a
first MD episode with a treatment prescribed between
January 2003 and March 2007 (determined for diagnosis
by clinical interview of treating clinicians according to
the ICPC-2), c) and demonstrate a period of at least six
months without depression prior to the MD episode, d)
prescription should follow the minimum required treat-
ment criteria [11] (> 60 days of AD treatment after the
f i r s tp r e s c r i p t i o n )a n de )af o l l o w - u po fa tl e a s t1 8
months (12-month study period and 6-month follow-up
to assign study sub-group). Two sub-groups were con-
sidered: patients in remission and patients not in
remission.
Definition of remission by approximation and according
to reference criteria
Patients were considered to be in remission when they
no longer required new prescriptions of AD for at least
six months after completing treatment of the first epi-
sode; patients who could only interrupt treatment for a
period less than six months were not considered in sus-
tained remission [12]. As reference criteria, remission
was determined based on the assessment of the database
clinical course text by a psychiatry specialist. The sam-
ple was selected through simple random sampling strati-
fied for age and gender. Sample size was calculated
assuming an expected remission prevalence of 54%, a
random error of 5% (bilateral) and an accuracy of 8.5%.
Validity and utility measure indicators
Validity indicators were Sensitivity [S], specificity [Sp],
positive and negative predictive value [PPV] and [NPV])
and clinical utility (positive and negative probability
ratio [PPR] and [NPR]. S is the probability of obtaining
a positive result when the subject meets the approxima-
tion definition. Sp indicates the probability of obtaining
a negative result when the subject does not meet the
approximation definition. PPV is the probability of
meeting the reference criteria when the approximate
remission variable is positive. NPV is the probability of
not meeting the reference criteria when remission by
approximation is negative. The probability ratios of posi-
tive or negative likelihood-ratios indicate up to what
point a certain result in a diagnostic test will increase or
diminish pre-test probability [16].
Confidentiality of the information and statistical analysis
Data confidentiality was respected at all times, according
to the Personal Data Protection Act (Ley de protección
de Datos de Carácter Personal [LOPD]); this study was
approved by the Ethics Committee of Gol i Gurina
Foundation. Concordance between both remission mea-
surements was evaluated, itemized by systematic error
and random error. Concordance index was calculated
using Cohen’s kappa coefficient, correlation coefficient
was calculated for random error and McNemar test for
systematic error [17]. Reliability analysis was established
using Cronbach’s alpha. Confidence intervals [CI] of
95% were calculated. SPSSWIN version 12 was used,
establishing a statistic significance of p < 0.05.
Results
4,572 subjects, according to the database criteria, com-
plied with the selection (new episode of depression), of
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to be in remission. 133 patient histories were reviewed
according to clinical criteria. Concordance between
remission by approximation and remission according to
reference criteria is detailed in table 1. The weighted
kappa concordance index obtained was 82.8% (CI of
95%: 73.1 - 92.6), PPR 9.8% and NPR 0.1%. Eleven
patients showed discrepancies between remission by
approximation and remission according to reference cri-
teria. In five cases (false positives), review of the clinical
course revealed they did not meet the clinical criteria
for remission, the cause of this discrepancy was either
incorrect initial diagnostic classification or on later
occurrence of stress factors (dysthymia: 2; recurrent
depression: 1; adaptive disorder: 1; and vital occurrence:
1). Six patients (false negatives) were in remission by
clinical course assessment but not approximation cri-
teria. These patients were wrongly classified (dysthymia:
4; adaptive disorder: 1; recurrent depression: 1) and
required treatment to prevent recurrence for a longer
period of time.
Discussion
Our study deals with the clinical validity of the measure-
ment of remission in patients with major depression, as
obtained from population databases. It is worth pointing
out that the organization of care, through territorial-
based assignment of teams and the increasing computer-
ization of its centres provides a suitable environment to
carry out these types of studies in a clinical practice
environment [18,19]. Thus, the quality of the measure-
ments is a basic aspect in achieving an efficient health
system, and we must be sure in any kind of biomedical
research that measurement error is reasonably small. In
regulated environments, such as clinical testing in the
development of pharmaceuticals, data quality and espe-
cially measurement procedures require attention for rea-
sons related to both ethics and efficiency [17].
The results of our study reveal an acceptable degree of
concordance between the remission by approximation
and the variable obtained from patient history reviews
(reference criteria). The main cause of discrepancy
between them is diagnostic accuracy by the PC team. In
this respect, several authors have affirmed the existing
variability between the PC diagnosis and the one by
mental health specialists [20-22]. There seems to be cer-
tain difficulty in identifying affective and adaptive disor-
ders, which has an impact on remission measurement.
There are several possible motives affecting MD diagno-
sis. On one hand, it may be affected by shortcomings in
the training of the professionals, health care pressure in
their consults and the brief amount of time they can
devote to each patient.
Furthermore, it can also affect the classification system
used (ICPC-2), which can condition the diagnosis of
these patients. In this regard, it must be taken into con-
sideration that these differences between both disorders
make differential diagnoses difficult, as PC doctors
usually tend to view disorders from a dimensional rather
than a categorical perspective, probably because it best
fits the needs of their consultation. Nevertheless, there
are studies that reveal a certain tendency of over-diag-
nosis of depression disorders, while others point out an
under-diagnosis of MD and anxiety in PC [23,24]. The
interpretation of the measurement of remission in our
study may be in agreement with the interpretation of
probability coefficients (PPR and NPR) as the measure-
ment of clinical utility. Thus, the measurement of remis-
sion by approximation can generate moderate changes
from pre-test to post-test probability (reference criteria).
Possible limitations in the study demand caution in
generalization of results. The study presented is framed
within the studies known as technique validation in clin-
ical effectiveness conditions; therefore, the bias assumed
in research is typical of a study with a cross-sectional
model, oriented towards validation of diagnostic criteria.
M o r e o v e r ,s a m p l es i z ec a nh a v eah i g hr a n d o mc o m p o -
nent for precision in measurement, and the study was
carried out based on a specialist’s diagnostic criteria;
Table 1 Validity of remission by approximation in major
depression
Validation Method Reference Criteria
Remission by Approximation Clinical Histories
N = 133 Positive Negative
Positive 74 5
Negative 6 48
Statistics Value (%) 95% CI
Validity of the measurement
Sensitivity 92.5 88.0 - 96.9
Specificity 90.6 85.6 - 95.6
Positive predictive value 93.7 89.6 - 97.8
Negative predictive value 88.9 83.6 - 94.2
False positives 7.5 3.0 - 11.9
False negatives 9.4 4.4 - 14.4
Reliability
Cronbach’s alpha 90.6 85.6 - 95.6
Area under the curve 91.2 86.5 - 96.1
Concordance
McNemar test 58.1 49.7 - 66.5
Pearson correlation 82.8 73.1 - 92.5
Weighted kappa (Cohen) 82.8 73.1 - 92.6
Clinical utility
Positive Probability Ratio 9.8 —
Negative Probability Ratio 0.1 —
Reference criteria: Review of patients’ histories. Significance: p < 0.001 in all
cases. CI: confidence intervals
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professional’s characteristics.
Conclusions
Results show acceptable concordance in the remission
obtained from the computerized databases. The largest
discrepancies are in diagnostic accuracy.
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